Literature DB >> 23266879

Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model.

Christine A Curcio1, Jeffrey D Messinger, Kenneth R Sloan, Gerald McGwin, Nancy E Medeiros, Richard F Spaide.   

Abstract

PURPOSE: To characterize the morphology, prevalence, and topography of subretinal drusenoid deposits, a candidate histological correlate of reticular pseudodrusen, with reference to basal linear deposit (BlinD), a specific lesion of age-related macular degeneration, and to propose a biogenesis model for both lesion.
METHODS: Donor eyes with median death-to-preservation of 2:40 hours were postfixed in osmium tannic acid paraphenylenediamine and prepared for macula-wide high-resolution digital sections. Annotated thicknesses of 21 chorioretinal layers were determined at standard locations in sections through the fovea and the superior perifovea.
RESULTS: In 22 eyes of 20 white donors (83.1 ± 7.7 years), SDD appeared as isolated or confluent drusenoid dollops punctuated by tufts of retinal pigment epithelium apical processes and associated with photoreceptor perturbation. Subretinal drusenoid deposits and BlinD were detected in 85 and 90% of non-neovascular age-related macular degeneration donors, respectively. Subretinal drusenoid deposit was thick (median, 9.4 μm) and more abundant in the perifovea than in the fovea (P < 0.0001). BlinD was thin (median, 2.1 μm) and more abundant in the fovea than in the perifovea (P < 0.0001).
CONCLUSION: Subretinal drusenoid deposits and BlinD prevalence in age-related macular degeneration eyes are high. Subretinal drusenoid deposits organized morphology, topography, and impact on surrounding photoreceptors imply specific processes of biogenesis. Contrasting topographies of subretinal drusenoid deposits and BlinD suggest relationships with differentiable aspects of rod and cone physiology, respectively. A 2-lesion 2-compartment biogenesis model incorporating outer retinal lipid homeostasis is presented.

Entities:  

Mesh:

Year:  2013        PMID: 23266879      PMCID: PMC3870202          DOI: 10.1097/IAE.0b013e31827e25e0

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  83 in total

1.  Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation.

Authors:  S Y Cohen; L Dubois; R Tadayoni; C Delahaye-Mazza; C Debibie; G Quentel
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

2.  Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration.

Authors:  Shirley Sarks; Svetlana Cherepanoff; Murray Killingsworth; John Sarks
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

3.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

4.  The epidemiology of retinal reticular drusen.

Authors:  Ronald Klein; Stacy M Meuer; Michael D Knudtson; Sudha K Iyengar; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2007-11-28       Impact factor: 5.258

5.  Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy.

Authors:  Martin Rudolf; Mark E Clark; Melissa F Chimento; Chuan-Ming Li; Nancy E Medeiros; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

6.  Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.

Authors:  Jie Jin Wang; Elena Rochtchina; Anne J Lee; Ee-Munn Chia; Wayne Smith; Robert G Cumming; Paul Mitchell
Journal:  Ophthalmology       Date:  2007-01       Impact factor: 12.079

7.  Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration.

Authors:  R Theodore Smith; Jackie K Chan; Mihai Busuoic; Vasuki Sivagnanavel; Alan C Bird; N Victor Chong
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-12       Impact factor: 4.799

8.  Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration.

Authors:  Lihua Y Marmorstein; Precious J McLaughlin; Neal S Peachey; Takako Sasaki; Alan D Marmorstein
Journal:  Hum Mol Genet       Date:  2007-07-30       Impact factor: 6.150

9.  Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch.

Authors:  Jiahn-Dar Huang; J Brett Presley; Melissa F Chimento; Christine A Curcio; Mark Johnson
Journal:  Exp Eye Res       Date:  2007-05-03       Impact factor: 3.467

10.  Sub-retinal drusenoid deposits in human retina: organization and composition.

Authors:  Martin Rudolf; Goldis Malek; Jeffrey D Messinger; Mark E Clark; Lan Wang; Christine A Curcio
Journal:  Exp Eye Res       Date:  2008-08-03       Impact factor: 3.467

View more
  143 in total

1.  Choriocapillaris' alterations in the presence of reticular pseudodrusen compared to drusen: study based on OCTA findings.

Authors:  Irini Chatziralli; George Theodossiadis; Dimitrios Panagiotidis; Paraskevi Pousoulidi; Panagiotis Theodossiadis
Journal:  Int Ophthalmol       Date:  2017-08-04       Impact factor: 2.031

Review 2.  The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity.

Authors:  D Kent
Journal:  Eye (Lond)       Date:  2015-07-31       Impact factor: 3.775

3.  The Onion Sign in Neovascular Age-Related Macular Degeneration Represents Cholesterol Crystals.

Authors:  Claudine E Pang; Jeffrey D Messinger; Emma C Zanzottera; K Bailey Freund; Christine A Curcio
Journal:  Ophthalmology       Date:  2015-08-19       Impact factor: 12.079

4.  Microstructure of subretinal drusenoid deposits revealed by adaptive optics imaging.

Authors:  Alexander Meadway; Xiaolin Wang; Christine A Curcio; Yuhua Zhang
Journal:  Biomed Opt Express       Date:  2014-02-12       Impact factor: 3.732

5.  Deletion of aryl hydrocarbon receptor AHR in mice leads to subretinal accumulation of microglia and RPE atrophy.

Authors:  Soo-Young Kim; Hyun-Jin Yang; Yi-Sheng Chang; Jung-Woong Kim; Matthew Brooks; Emily Y Chew; Wai T Wong; Robert N Fariss; Rivka A Rachel; Tiziana Cogliati; Haohua Qian; Anand Swaroop
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-26       Impact factor: 4.799

Review 6.  Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.

Authors:  Goldis Malek; Eleonora M Lad
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

Review 7.  Age-related macular degeneration: genetics and biology coming together.

Authors:  Lars G Fritsche; Robert N Fariss; Dwight Stambolian; Gonçalo R Abecasis; Christine A Curcio; Anand Swaroop
Journal:  Annu Rev Genomics Hum Genet       Date:  2014-04-16       Impact factor: 8.929

Review 8.  'Statins in retinal disease'.

Authors:  Ahmed Al-Janabi; Sue Lightman; Oren Tomkins-Netzer
Journal:  Eye (Lond)       Date:  2018-03-20       Impact factor: 3.775

Review 9.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

10.  Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels.

Authors:  Zsolt Ablonczy; Mohammad Dahrouj; Alexander G Marneros
Journal:  FASEB J       Date:  2014-02-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.